reasons think lonafranib works influencing rhes noting main targets enzyme drug blocks analyzed genes disrupted stem cell lines derived people tau mutations gene encodes rhes turned second researchers genetically manipulated rhes levels mice brains directly found reducing rhes reproduced effects obtained lonafranib treatment observation suggests drug lowers rhes levels turn activates lysosomal activity clears offending tau molecules intriguing therapeutic hypothesis says director alzheimer disease drug discovery development national institute aging department national institutes health not involved study lonafarnib extensively studied cancer research labeled breakthrough therapy hepatitis d fda drug significant safety profile different patient populations making attractive repurposing treatment tauopathies